JACOBSON PHARMA (02633): Huang Ziheng appointed as independent non-executive director
Jacobson Pharmaceutical (02633) announced that Mr. Huang Ziheng has been appointed as the company's independent non-executive director, chairman of the audit committee, and member of the nomination committee, effective from August 11, 2026, following Mr. Yang's resignation.
JACOBSON PHARMA (02633) announced that Mr. Wong Tze Hang has been appointed as the company's independent non-executive director, chairman of the audit committee, and member of the nomination committee, effective from August 11, 2026, following the resignation of Mr. Yang.
Dr. Lam Kwong Tong, the company's independent non-executive director, has resigned as a member of the nomination committee, while Mr. Lu Ting Lung, the independent non-executive director of the company, has been appointed as the chairman of the nomination committee and member of the remuneration committee, effective from August 11, 2026, following the resignation of Mr. Yang.
Related Articles
ABA Chemicals Corporation (300261.SZ) plans to raise no more than 841 million yuan through a private placement of stocks.
ADWAY (06189): Two project contracts have been signed, with a total contract value of approximately 73 million yuan.
SUNDART HLDGS (01568) released its interim results, with a profit attributable to shareholders of HKD 151 million, an increase of 11.7% year-on-year.
ABA Chemicals Corporation (300261.SZ) plans to raise no more than 841 million yuan through a private placement of stocks.
ADWAY (06189): Two project contracts have been signed, with a total contract value of approximately 73 million yuan.
SUNDART HLDGS (01568) released its interim results, with a profit attributable to shareholders of HKD 151 million, an increase of 11.7% year-on-year.
RECOMMEND
